Seth J Baum (Seth Baum)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Low Density Lipoprotein

Health Insurance

Placebo Controlled

Top Venues

Circulation. Cardiovascular quality and outcomes

Nature medicine

European heart journal

This page only lists publications with an associated author ORCID identifier.

Publications

Diane E MacDougall, Seth J Baum, Catherine D Ahmed, Mary P McGowan, Katherine A Wilemon
Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021. Circulation. Cardiovascular quality and outcomes 17 (2) (2024)
Diane E MacDougall, Seth J Baum, Catherine D Ahmed, Mary P McGowan, Katherine A Wilemon
Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021. Circulation. Cardiovascular quality and outcomes (2024)
Diane E MacDougall, Seth J Baum, Catherine D Ahmed, Mary P McGowan, Katherine A Wilemon
Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021. Circulation. Cardiovascular quality and outcomes 17 (2) (2024)
Diane E MacDougall, Seth J Baum, Catherine D Ahmed, Mary P McGowan, Katherine A Wilemon
Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021. Circulation. Cardiovascular quality and outcomes 17 (2) (2024)
Diane E MacDougall, Seth J Baum, Catherine D Ahmed, Mary P McGowan, Katherine A Wilemon
Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021. Circulation. Cardiovascular quality and outcomes 17 (2) (2024)
Robert S Rosenson, Daniel Gaudet, Christie M Ballantyne, Seth J Baum, Jean Bergeron, Erin E Kershaw, Patrick M Moriarty, Paolo Rubba, David C Whitcomb, Poulabi Banerjee, Andrew Gewitz, Claudia Gonzaga-Jauregui, Jennifer McGinniss, Manish P Ponda, Robert Pordy, Jian Zhao, Daniel James Rader
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. Nature medicine 29 (3) (2023)
Robert S Rosenson, Daniel Gaudet, Christie M Ballantyne, Seth J Baum, Jean Bergeron, Erin E Kershaw, Patrick M Moriarty, Paolo Rubba, David C Whitcomb, Poulabi Banerjee, Andrew Gewitz, Claudia Gonzaga-Jauregui, Jennifer McGinniss, Manish P Ponda, Robert Pordy, Jian Zhao, Daniel James Rader
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. Nature medicine (2023)
Albert Wiegman, Susanne Greber-Platzer, Shazia Ali, M Doortje Reijman, Eliot A Brinton, Min-Ji Charng, Shubha Srinivasan, Carissa M Baker-Smith, Seth J Baum, Julie A Brothers, Jacob Hartz, Patrick M Moriarty, Jeanne Mendell, Sébastien Bihorel, Poulabi Banerjee, Richard T George, Boaz Hirshberg, Robert Pordy
Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia. Circulation (2023)
Robert S Rosenson, Daniel Gaudet, Christie M Ballantyne, Seth J Baum, Jean Bergeron, Erin E Kershaw, Patrick M Moriarty, Paolo Rubba, David C Whitcomb, Poulabi Banerjee, Andrew Gewitz, Claudia Gonzaga-Jauregui, Jennifer McGinniss, Manish P Ponda, Robert Pordy, Jian Zhao, Daniel James Rader
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. Nature medicine 29 (3) (2023)
Robert S Rosenson, Daniel Gaudet, Christie M Ballantyne, Seth J Baum, Jean Bergeron, Erin E Kershaw, Patrick M Moriarty, Paolo Rubba, David C Whitcomb, Poulabi Banerjee, Andrew Gewitz, Claudia Gonzaga-Jauregui, Jennifer McGinniss, Manish P Ponda, Robert Pordy, Jian Zhao, Daniel James Rader
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. Nature medicine 29 (3) (2023)
Jean-Claude Tardif, Ewa Karwatowska-Prokopczuk, Eric St Amour, Christie M Ballantyne, Michael David Shapiro, Patrick M Moriarty, Seth J Baum, Eunju Hurh, Victoria J Bartlett, Joyce Kingsbury, Amparo L Figueroa, Veronica J Alexander, Joseph Tami, Joseph L Witztum, Richard S Geary, Louis St L O'Dea, Sotirios Tsimikas, Daniel Gaudet
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk. European heart journal 43 (14) (2022)